Establishment and characterization of ci
โ
Weon-Seon Hong; Nagahiro Saijo; Yasutsuna Sasaki; Koichi Minato; Hidehiko Nakano
๐
Article
๐
1988
๐
John Wiley and Sons
๐
French
โ 639 KB
Human lung cancer sublines resistant t o cisplatin (CDDP) have been developed by continuously exposing cells to gradually increasing doses of CDDP and use of the limiting dilution technique. The cell lines used were PC-7, PC-9 and PC-14 (pulmonary adenocarcinoma) and H69 and N23 I (small-cell lung c